1 |
Tang C, Liu J, Yang C, Ma J, Chen X, Liu D, Zhou Y, Zhou W, Lin Y, Yuan X. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations. Biomolecules 2022;12:1636. [DOI: 10.3390/biom12111636] [Reference Citation Analysis]
|
2 |
Lin A, Fang J, Cheng Q, Liu Z, Luo P, Zhang J. B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis. J Inflamm Res 2022;15:5541-55. [PMID: 36176353 DOI: 10.2147/JIR.S379016] [Reference Citation Analysis]
|
3 |
Liu R, Liang W, Hua Q, Wu L, Wang X, Li Q, Zhong F, Li B, Qiu Z. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma. Front Immunol 2022;13:819515. [DOI: 10.3389/fimmu.2022.819515] [Reference Citation Analysis]
|